# Laura Scott

> Laura Scott is a post-ipo debt investor at Silicon Valley Bank backing Health Care and Medical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Silicon Valley Bank](https://shizune.co/investors/profile/silicon-valley-bank)
- Location: Newton Lower Falls, United States
- Total investments: 2
- Last investment: Apr 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/laura-scott-376a5212/

Laura Scott is a post-ipo debt investor at Silicon Valley Bank in Newton Lower Falls focused on Health Care and Medical. Laura Scott is Head of Mid-Atlantic and Southeast Life Science and Healthcare at Silicon Valley Bank.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Medical | 1 | 50% |
| Software | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Debt | 1 | 50% |
| Debt Financing | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Glytec | Glytec is a personalized digital therapeutics, enabling practices for inpatient and outpatient insulin management. The company’s patented and FDA-cleared software-as-a-medical-device solutions improve the safety and health of people with diabetes and make insulin a more effective medication option for millions who are unable to achieve theirtreatment goals. Glytec combines evidence-based decision support technologies with expert clinical services to optimize basal and bolus insulin therapies in the hospital and at home, leading to reductions in hypoglycemia and other complications as well as avoidable ED visits, hospitalizations, readmissions, and drug waste. The company has offices in Waltham, Massachusetts, and Greenville, South Carolina. | $9M | Debt Financing | Apr 26, 2021 |  |
| Motus GI | Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System to improve the colonoscopy experience and assist in the early detectionand prevention of colorectal cancer and other diseases of the rectum and colon. | $8M | Post-IPO Debt | Dec 18, 2019 |  |

2 of 2 investments shown.

## About Silicon Valley Bank

VC Fund · Santa Clara, United States

Silicon Valley Bank works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven internationaloperations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.

5 contacts available at Silicon Valley Bank.

| Name | Title | Profile |
| --- | --- | --- |
| Dennis Grunt | Director | https://shizune.co/investors/profile/dennis-grunt |
| Keith Cox | Head of Sponsor and Leveraged Finance | https://shizune.co/investors/profile/keith-cox-4 |
| Laura Scott | Managing Director | https://shizune.co/investors/profile/laura-scott-b21d |
| Nicole Hawkey | Director | https://shizune.co/investors/profile/nicole-hawkey |
| Alex McCracken | Managing Director | https://shizune.co/investors/profile/alex-mccracken |

## Similar investors

### Similar stage
- [BNP Paribas](https://shizune.co/investors/profile/bnp-paribas) — VC Fund
- [Intesa Sanpaolo](https://shizune.co/investors/profile/intesa-sanpaolo) — VC Fund
- [UniCredit](https://shizune.co/investors/profile/unicredit) — VC Fund

## FAQ

### What does Laura Scott invest in?

Laura Scott invests primarily in Health Care, Medical and Software startups, most often at Post-IPO Debt and Debt Financing stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Laura Scott last invest?

The most recent investment recorded for Laura Scott closed in Apr 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co